Bolt Biotherapeutics
Redwood City, CA
Bolt Biotherapeutics, Inc. operates as a biotechnology company. The Company develops immune-stimulating antibody conjugates, a new class of cancer therapeutics, which systemically-administered and uncover the immune system to induce anti-tumor immunity. Bolt Biotherapeutics serves healthcare industry in the United States.
boltbio.comCompany Details
Founded
- 2015
Employees
- 52 employees
Raised
- $198,500,000
Headquarters Location
- Redwood City, CA
Public
- Yes
Acquired
- No
CEO
Willie Quinn
Founders
- Ed EnglemanChih-Ping Liu
Company Collections
These are collections Bolt Biotherapeutics is a part of. Click on the collection name to view similar companies.
Bolt Biotherapeutics' Industries
Bolt Biotherapeutics Headquarters Location
Total Amount Raised: $198,500,000
Bolt Biotherapeutics Funding Rounds
Post Ipo Equity
$15,000,000
Post Ipo Equity Investors
GenmabIPO
Unknown
Series C
$93,500,000
Series C Investors
Sofinnova VenturesRock Springs CapitalRA Capital ManagementNovo HoldingsPivotal bioVenture PartnersSurveyor CapitalVivo CapitalPfizer Venture InvestmentsSamsara BioCapitalSeries B
$54,000,000
Series B Investors
Pivotal bioVenture PartnersNan Fung Life SciencesNovo HoldingsVivo CapitalSeries Unknown
$19,400,000
Series Unknown
$6,000,002
Series Unknown
$9,999,998
Seed
$600,000
Bolt Biotherapeutics Reviews
0 out of 5 stars
Based on 0 reviews
Review data
Share your thoughts
Worked here? Share your experience. Help others decide if this company is right for them. Write a review on Bolt Biotherapeutics.